Abstract
Objectives: Neonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury. Methods: Rat pups were subjected to unilateral carotid artery ligation followed by 2.5. h of hypoxia. Animals were randomly assigned to five groups: Sham (n = 15), vehicle (HI, n = 15), HI with G-CSF treatment (n = 15), HI with G-CSF + Ab treatment (n = 15), and HI with Ab treatment (n = 15). Ab (325 μg/kg) was administered intraperitoneally while G-CSF (50 μg/kg) was administered subcutaneously 1. h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96. h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5. weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed. Results: The G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF + Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF + Ab group. No significant differences were found in peripheral organ weights between groups. Conclusion: Our data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided. © 2014 Elsevier Inc.
Original language | English |
---|---|
Pages (from-to) | 192-199 |
Number of pages | 8 |
Journal | Neurobiology of Disease |
Volume | 69 |
DOIs | |
State | Published - Sep 2014 |
ASJC Scopus Subject Areas
- Neurology
Keywords
- Anti-neutrophil antibody (Ab)
- Granulocyte-colony stimulating factor (G-CSF)
- Hypoxia-ischemia (HI)
- Neonatal
- Neurological function
- Neutrophil
- Animals, Newborn
- Neuroprotective Agents/administration & dosage
- Severity of Illness Index
- Hypoxia-Ischemia, Brain/blood
- Antibodies/administration & dosage
- Combined Modality Therapy
- Random Allocation
- Spleen/drug effects
- Rats, Sprague-Dawley
- Recovery of Function/drug effects
- Atrophy
- Brain/drug effects
- Granulocyte Colony-Stimulating Factor/administration & dosage
- Neutrophils/immunology
- Animals
- Leukocyte Count
- Lung/drug effects
- Disease Models, Animal